BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7665235)

  • 1. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells.
    Antalis TM; Reeder JA
    Int J Cancer; 1995 Sep; 62(5):619-26. PubMed ID: 7665235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium butyrate differentially modulates plasminogen activator inhibitor type-1, urokinase plasminogen activator, and its receptor in a human colon carcinoma cell.
    Reeder JA; Dickinson JL; Chenevix-Trench G; Antalis TM
    Teratog Carcinog Mutagen; 1993; 13(2):75-88. PubMed ID: 8102211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
    Lund LR
    FEBS Lett; 1996 Apr; 383(3):139-44. PubMed ID: 8925884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells.
    Dang J; Wang Y; Doe WF
    FEBS Lett; 1995 Feb; 359(2-3):147-50. PubMed ID: 7867787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
    Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
    Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937.
    Peiretti F; Fossat C; Anfosso F; Alessi MC; Henry M; Juhan-Vague I; Nalbone G
    Blood; 1996 Jan; 87(1):162-73. PubMed ID: 8547638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
    Moreau M; Mourah S; Dosquet C
    Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.
    Wang Y; Dang J; Liang X; Doe WF
    Clin Exp Metastasis; 1995 May; 13(3):196-202. PubMed ID: 7750207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissue.
    Usher PA; Thomsen OF; Iversen P; Johnsen M; Brünner N; Høyer-Hansen G; Andreasen P; Danø K; Nielsen BS
    Int J Cancer; 2005 Mar; 113(6):870-80. PubMed ID: 15515049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
    J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system.
    Medcalf RL
    J Biol Chem; 1992 Jun; 267(17):12220-6. PubMed ID: 1318313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.
    Illemann M; Bird N; Majeed A; Laerum OD; Lund LR; Danø K; Nielsen BS
    Int J Cancer; 2009 Apr; 124(8):1860-70. PubMed ID: 19123477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients.
    Kotzsch M; Magdolen V; Greither T; Kappler M; Bache M; Lautenschläger C; Füssel S; Eckert AW; Luther T; Baretton G; Würl P; Taubert H
    BMC Cancer; 2011 Jun; 11():273. PubMed ID: 21702998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C; Yu J; Huang S
    Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.